Positions

Overview

  • Stuart J. Frank (b. 1958, Wilkes-Barre, PA), Professor of Medicine, Cell Biology, and Physiology, received his B.A. summa cum laude in 1980 as a Benjamin Franklin Scholar at the University of Pennsylvania. He earned his M.D. in 1984 from Harvard Medical School. After residency in Internal Medicine at Washington University in St. Louis, Dr. Frank began fellowship training at the National Institutes of health from 1987 to 1991. His research there in Dr. Richard Klausner’s laboratory focused on T-cell antigen receptor signal transduction. Dr. Frank has been a UAB faculty member since 1991 in the Division of Endocrinology and Metabolism in the Department of Medicine, where his studies are aimed at understanding growth hormone (GH) receptor signal transduction and structure/function relationships and mechanisms of generation of the GH binding protein. He is also Chief of the Endocrinology Section in the Medical Service at the Birmingham Veterans Affairs Medical Center. His research is supported by grants from NIH and the Department of Veterans Affairs.

    • Selected Publications

    Academic Article

    Year Title Altmetric
    2020 Differential effects of REV-ERB/ agonism on cardiac gene expression, metabolism, and contractile function in a mouse model of circadian disruption 2020
    2020 Insulin-Like Growth Factors Are Key Regulators of T Helper 17 Regulatory T Cell Balance in Autoimmunity.  Immunity.  52:650-667.e10. 2020
    2020 Autocrine/paracrine actions of growth hormone in human melanoma cell lines.  Biochemistry and Biophysics Reports.  21. 2020
    2019 Growth hormone (GH) receptor (GHR)-specific inhibition of GH-Induced signaling by soluble IGF-1 receptor (sol IGF-1R).  Molecular and Cellular Endocrinology.  492. 2019
    2018 Moving Career Development Upstream: Evaluation of a Course for Internal Medicine Trainees Contemplating Career Pathways in Academic Medicine.  Southern Medical Journal.  111:471-475. 2018
    2018 Differential tissue response to growth hormone in mice.  FEBS Open Bio.  8:1146-1154. 2018
    2018 Temporal partitioning of adaptive responses of the murine heart to fasting.  Life Sciences.  197:30-39. 2018
    2018 Effects of rapamycin on growth hormone receptor knockout mice 2018
    2017 Subdomain 2, not the transmembrane domain, determines the dimerization partner of growth hormone receptor and prolactin receptor.  Endocrinology.  158:3235-3248. 2017
    2017 Genetic disruption of the cardiomyocyte circadian clock differentially influences insulin-mediated processes in the heart.  Journal of Molecular and Cellular Cardiology.  110:80-95. 2017
    2017 Molecular interactions of EphA4, growth hormone receptor, Janus kinase 2, and signal transducer and activator of transcription 5B.  PLoS ONE.  12. 2017
    2017 Insulin, IGF-1, and GH receptors are altered in an adipose tissue depot-specific manner in male mice with modified GH action.  Endocrinology.  158:1406-1418. 2017
    2016 TIMP3 modulates GHR abundance and GH sensitivity 2016
    2016 Calcium channel blocker use is associated with lower fasting serum glucose among adults with diabetes from the REGARDS study.  Diabetes Research and Clinical Practice.  115:115-121. 2016
    2016 GHR/PRLR heteromultimer is composed of GHR homodimers and PRLR homodimers 2016
    2015 Augmented STAT5 signaling bypasses multiple impediments to lactogen-mediated proliferation in human β-cells.  Diabetes.  64:3784-3797. 2015
    2015 Growth hormone inhibits hepatic de novo lipogenesis in adult mice.  Diabetes.  64:3093-3103. 2015
    2014 Distinct mechanisms of induction of hepatic growth hormone resistance by endogenous IL-6, TNF-α, and IL-1β 2014
    2014 Functional collaboration of insulin-like growth factor-1 receptor (IGF-1R), but not insulin receptor (IR), with acute GH signaling in mouse calvarial cells.  Endocrinology.  155:1000-1009. 2014
    2014 Circadian clock control of endocrine factors.  Nature Reviews Endocrinology.  10:466-475. 2014
    2014 Dynamic analysis of gh receptor conformational changes by split luciferase complementation 2014
    2014 Human gh Receptor-Igf-1 receptor interaction: Implications for gh signaling 2014
    2014 Human gh Receptor-Igf-1 receptor interaction: Implications for gh signaling 2014
    2013 IGF-1R modulation of acute GH-induced STAT5 signaling: Role of protein tyrosine phosphatase activity 2013
    2013 Hepatic growth hormone resistance after acute injury.  Endocrinology.  154:1577-1588. 2013
    2013 The role of GH in adipose tissue: Lessons from adipose-specific GH receptor gene-disrupted mice 2013
    2013 The role of prolactin receptor in GH signaling in breast cancer cells 2013
    2013 Effects of insulin and IGF-I on growth hormone- induced STAT5 activation in 3T3-F442A adipocytes.  Lipids in Health and Disease.  12. 2013
    2012 Noninvasive bioluminescence imaging in small animals 2012
    2012 Growth hormone-induced JAK2 signaling and GH receptor down-regulation: Role of GH receptor intracellular domain tyrosine residues.  Endocrinology.  153:2311-2322. 2012
    2012 Innate dysfunction promotes linear growth failure in pediatric Crohn's disease and growth hormone resistance in murine ileitis.  Inflammatory Bowel Diseases.  18:236-245. 2012
    2011 Inhibitory GH receptor extracellular domain monoclonal antibodies: Three-dimensional epitope mapping.  Endocrinology.  152:4777-4788. 2011
    2011 Signaling cross talk between growth hormone (GH) and insulin-like growth factor-I (IGF-I) in pancreatic islet β-cells 2011
    2011 ACK2-dependent mechanism for activation of the JAK-STAT signaling pathway.  Blood.  118:156-166. 2011
    2011 γ-Secretase-mediated growth hormone receptor proteolysis: Mapping of the intramembranous cleavage site.  Biochemical and Biophysical Research Communications.  408:432-436. 2011
    2011 Growth hormone signaling in human T47D breast cancer cells: Potential role for a growth hormone Receptor-Prolactin receptor complex 2011
    2011 Synergy in ERK activation by cytokine receptors and tyrosine kinase growth factor receptors.  Cellular Signalling.  23:417-424. 2011
    2010 Distinct growth hormone receptor signaling modes regulate skeletal muscle development and insulin sensitivity in mice.  Journal of Clinical Investigation.  120:4007-4020. 2010
    2010 Deletion of IGF-I receptor (IGF-IR) in primary osteoblasts reduces GH-induced STAT5 signaling 2010
    2010 Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth.  Nature Medicine.  16:219-223. 2010
    2010 Erratum to "Effects of diabetes mellitus in patients with heart failure and chronic kidney disease: A propensity-matched study of multimorbidity in chronic heart failure" [Int. J. Cardiol. 134 (2009) 330-335] (DOI:10.1016/j.ijcard.2008.12.089).  International Journal of Cardiology.  138:106. 2010
    2010 Growth hormone receptor targeting to lipid rafts requires extracellular subdomain 2.  Biochemical and Biophysical Research Communications.  391:414-418. 2010
    2009 Effects of diabetes mellitus in patients with heart failure and chronic kidney disease: A propensity-matched study of multimorbidity in chronic heart failure.  International Journal of Cardiology.  134:330-335. 2009
    2009 Extreme elevation of serum growth hormone-binding protein concentrations resulting from a novel heterozygous splice site mutation of the growth hormone receptor gene 2009
    2009 Erratum: Mode of growth hormone action in osteoblasts (Journal of Biological Chemistry (2007) vol. 282 (31666-31674)).  Journal of Biological Chemistry.  284:10992. 2009
    2009 Interruption of growth hormone signaling via SHC and ERK in 3T3-F442A preadipocytes upon knockdown of insulin receptor substrate-1 2009
    2008 Modulation of growth hormone receptor abundance and function: roles for the ubiquitin-proteasome system 2008
    2008 ERK-dependent threonine phosphorylation of EGF receptor modulates receptor downregulation and signaling.  Cellular Signalling.  20:2145-2155. 2008
    2008 Tight blood glucose control (1) 2008
    2008 Endotoxin-induced proteolytic reduction in hepatic growth hormone (GH) receptor: A novel mechanism for GH insensitivity 2008
    2008 Activation of growth hormone receptors by growth hormone and growth hormone antagonist dimers: Insights into receptor triggering 2008
    2008 Mechanistic aspects of crosstalk between GH and PRL and ErbB receptor family signaling.  Journal of Mammary Gland Biology and Neoplasia.  13:119-129. 2008
    2008 Prolactin stimulates ubiquitination, initial internalization, and degradation of its receptor via catalytic activation of Janus kinase 2.  Journal of Endocrinology.  196. 2008
    2008 Noninvasive bioluminescence imaging in small animals 2008
    2007 Endoplasmic reticulum-associated degradation of growth hormone receptor in Janus kinase 2-deficient cells.  Endocrinology.  148:5955-5965. 2007
    2007 Photic injury promotes cleavage of p75NTR by TACE and nuclear trafficking of the p75 intracellular domain.  Molecular and Cellular Neuroscience.  36:449-461. 2007
    2007 Mode of growth hormone action in osteoblasts.  Journal of Biological Chemistry.  282:31666-31674. 2007
    2007 Effect of nutrition on the GH responsiveness of liver and adipose tissue in dairy cows.  Journal of Endocrinology.  195:49-58. 2007
    2007 Combined effect of mutations of the GH1 gene and its proximal promoter region in a child with growth hormone neurosecretory dysfunction (GHND) 2007
    2007 A growth hormone receptor mutation impairs growth hormone autofeedback signaling in pituitary tumors.  Cancer Research.  67:7505-7511. 2007
    2007 Determinants of growth hormone receptor down-regulation 2007
    2007 Growth hormone stimulates hepatic expression of bovine growth hormone receptor messenger ribonucleic acid through signal transducer and activator of transcription 5 activation of a major growth hormone receptor gene promoter.  Endocrinology.  148:3307-3315. 2007
    2007 Role of the Growth Hormone (GH) receptor transmembrane domain in receptor predimerization and GH-induced activation 2007
    2007 Identification of the glomerular podocyte as a target for growth hormone action.  Endocrinology.  148:2045-2055. 2007
    2007 Growth hormone, insulin-like growth factor I, and growth: Local knowledge.  Endocrinology.  148:1486-1488. 2007
    2007 Tumour necrosis factor α blockade induces an anti-inflammatory growth hormone signalling pathway in experimental colitis.  Gut.  56:73-81. 2007
    2006 Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.  Oncogene.  25:7565-7576. 2006
    2006 In vivo imaging of hepatic growth hormone signaling 2006
    2006 Growth hormone/JAK-STAT axis signal-transduction defect: A novel treatable cause of growth failure 2006
    2006 Janus kinase 2 influences growth hormone receptor metalloproteolysis.  Endocrinology.  147:2839-2849. 2006
    2006 A mutant signal transducer and activator of transcription 5b, associated with growth hormone insensitivity and insulin-like growth factor-I deficiency, cannot function as a signal transducer or transcription factor.  Journal of Clinical Endocrinology and Metabolism.  91:1526-1534. 2006
    2006 Insulin enhances growth hormone induction of the MEK/ERK signaling pathway.  Journal of Biological Chemistry.  281:982-992. 2006
    2006 Signal transducer and activator of transcription 5b promotes mucosal tolerance in pediatric Crohn's disease and murine colitis.  American Journal of Pathology.  169:1999-2013. 2006
    2005 Janus kinase 2 enhances the stability of the mature growth hormone receptor.  Endocrinology.  146:4755-4765. 2005
    2005 Growth hormone receptor is a target for presenilin-dependent γ-secretase cleavage.  Journal of Biological Chemistry.  280:19331-19342. 2005
    2005 Partial redirection of transgenic human growth hormone secretion from rat salivary glands.  Human Gene Therapy.  16:571-583. 2005
    2005 Identification of 1,2,3,4,5,6-hexabromocyclohexane as a small molecule inhibitor of Jak2 tyrosine kinase autophophorylation.  Journal of Medicinal Chemistry.  48:2526-2533. 2005
    2004 A conformationally sensitive GHR [Growth Hormone (GH) Receptor] antibody: Impact on GH signaling and GHR proteolysis 2004
    2004 Microarray analyses identify JAK2 tyrosine kinase as a key mediator of ligand-independent gene expression 2004
    2004 Growth hormone alters epidermal growth factor receptor binding affinity via activation of extracellular signal-regulated kinases in 3T3-F442A cells.  Endocrinology.  145:3297-3306. 2004
    2004 Physical and functional interaction of growth hormone and insulin-like growth factor-I signaling elements 2004
    2004 Caveolar and lipid raft localization of the growth hormone receptor and its signaling elements: Impact on growth hormone signaling.  Journal of Biological Chemistry.  279:20898-20905. 2004
    2004 Dairy cows experience selective reduction of the hepatic growth hormone receptor during the periparturient period.  Journal of Endocrinology.  181:281-290. 2004
    2004 Insulin Increases the Abundance of the Growth Hormone Receptor in Liver and Adipose Tissue of Periparturient Dairy Cows 2004
    2003 Janus Kinase 2 Determinants for Growth Hormone Receptor Association, Surface Assembly, and Signaling 2003
    2003 Reduced Proteolysis of Rabbit Growth Hormone (GH) Receptor Substituted with Mouse GH Receptor Cleavage Site 2003
    2003 Effects of chronic ethanol on hepatic and renal CYP2C11 in the male rat: Interactions with the Janus-kinase 2-signal transducer and activators of transcription proteins 5b pathway.  Endocrinology.  144:3969-3976. 2003
    2003 Ovine placental lactogen-induced heterodimerization of ovine growth hormone and prolactin receptors in living cells is demonstrated by fluorescence resonance energy transfer microscopy and leads to prolonged phosphorylation of signal transducer and activator of transcription (STAT)1 and STAT3.  Endocrinology.  144:3532-3540. 2003
    2003 Growth hormone-induced phosphorylation of epidermal growth factor (EGF) receptor in 3T3-F442A cells: Modulation of EGF-induced trafficking and signaling.  Journal of Biological Chemistry.  278:18902-18913. 2003
    2003 Interleukin-6 inhibits hepatic growth hormone signaling via upregulation of Cis and Socs-3 2003
    2002 Metalloprotease-mediated GH receptor proteolysis and GHBP shedding: Determination of extracellular domain stem region cleavage site.  Journal of Biological Chemistry.  277:50510-50519. 2002
    2002 A role for Grb2-associated binder-1 in growth hormone signaling.  Endocrinology.  143:4856-4867. 2002
    2002 Metalloproteinases and the modulation of GH signaling.  Journal of Endocrinology.  174:361-368. 2002
    2002 Growth hormone-induced differential desensitization of STAT5, ERK, and Akt phosphorylation.  Journal of Biological Chemistry.  277:28384-28393. 2002
    2002 Impairment of Liver GH Receptor Signaling by Fasting..  Endocrinology.  143:792-800. 2002
    2002 Impairment of liver GH receptor signaling by fasting.  Endocrinology.  143:792-800. 2002
    2002 Minireview: Receptor Dimerization in GH and Erythropoietin Action-It Takes Two to Tango, But How?.  Endocrinology.  143:2-10. 2002
    2002 Minireview: Receptor dimerization in GH and erythropoietin action - It takes two to Tango, but how?.  Endocrinology.  143:2-10. 2002
    2001 Growth Hormone (GH)-induced Dimerization Inhibits Phorbol Ester-stimulated GH Receptor Proteolysis.  Journal of Biological Chemistry.  276:24565-24573. 2001
    2001 Demonstration of Direct Effects of Growth Hormone on Neonatal Cardiomyocytes.  Journal of Biological Chemistry.  276:22892-22900. 2001
    2001 Pulmonary hypoplasia in mice lacking tumor necrosis factor-α converting enzyme indicates an indispensable role for cell surface protein shedding during embryonic lung branching morphogenesis.  Developmental Biology.  232:204-218. 2001
    2001 The Angiotensin II-dependent Nuclear Translocation of Stat1 is Mediated by the Jak2 Protein Motif 231YRFRR.  Journal of Biological Chemistry.  276:10556-10563. 2001
    2001 Constitutive α-secretase cleavage of the β-amyloid precursor protein in the furin-deficient LoVo cell line: Involvement of the pro-hormone convertase 7 and the disintegrin metalloprotease ADAM10.  Journal of Neurochemistry.  76:1532-1539. 2001
    2001 Src homology 3 domain-dependent interaction of Nck-2 with insulin receptor substrate-1.  Biochemical Journal.  354:315-322. 2001
    2001 Growth hormone signalling and its regulation: Preventing too much of a good thing.  Growth Hormone and IGF Research.  11:201-212. 2001
    2001 Phorbol ester- and growth factor-induced growth hormone (GH) receptor proteolysis and GH-binding protein shedding: Relationship to GH receptor down-regulation.  Endocrinology.  142:1137-1147. 2001
    2000 Tumor Necrosis Factor-α Converting Enzyme (TACE) Is a Growth Hormone Binding Protein (GHBP) Sheddase: The Metalloprotease TACE/ADAM-17 Is Critical for (PMA-Induced) GH Receptor Proteolysis and GHBP Generation..  Endocrinology.  141:4342-4348. 2000
    2000 Insulin receptor substrate-1-mediated enhancement of growth hormone-induced mitogen-activated protein kinase activation.  Endocrinology.  141:3328-3336. 2000
    2000 Tumor necrosis factor-α converting enzyme (TACE) is a growth hormone binding protein (GHBP) sheddase: The metalloprotease TACE/ADAM-17 is critical for (PMA-induced) GH receptor proteolysis and GHBP generation.  Endocrinology.  141:4342-4348. 2000
    1999 Growth hormone-induced alteration in ErbB-2 phosphorylation status in 3T3-F442A fibroblasts.  Journal of Biological Chemistry.  274:36015-86024. 1999
    1999 A catalytically active Jak2 is required for the angiotensin II-dependent activation of Fyn.  Journal of Biological Chemistry.  274:33131-33142. 1999
    1999 Disulfide linkage of growth hormone (GH) receptors (GHR) reflects GH- induced GHR dimerization. Association of JAK2 with the GHR is enhanced by receptor dimerization.  Journal of Biological Chemistry.  274:33072-33084. 1999
    1999 Developmental regulation of insulin-like growth factor-I and growth hormone receptor gene expression.  Molecular and Cellular Endocrinology.  152:125-136. 1999
    1999 The angiotensin II-dependent association of Jak2 and c-Src requires the N-terminus of Jak2 and the SH2 domain of c-Src.  Circulation Research.  84:1332-1338. 1999
    1999 Insulin inhibits growth hormone signaling via the growth hormone receptor/JAK2/STAT5B pathway.  Journal of Biological Chemistry.  274:13434-13442. 1999
    1999 Growth hormone-mediated regulation of insulin-like growth factor I promoter activity in C6 glioma cells.  Endocrinology.  140:3073-3081. 1999
    1999 Insulin receptor substrate-1 enhances growth hormone-induced proliferation.  Endocrinology.  140:1972-1983. 1999
    1998 Growth hormone-dependent tyrosine phosphorylation of a GH receptor-associated high molecular weight protein immunologically related to JAK2.  Biochemical and Biophysical Research Communications.  253:774-779. 1998
    1998 Involvement of the Src homology 2-containing tyrosine phosphatase SHP-2 in growth hormone signaling.  Journal of Biological Chemistry.  273:2344-2354. 1998
    1998 Blockade of growth hormone receptor shedding by a metalloprotease inhibitor.  Endocrinology.  139:1927-1935. 1998
    1997 Growth hormone induces detergent insolubility of GH receptors in IM-9 cells 1997
    1996 Growth hormone receptor cytoplasmic domain differentially promotes tyrosine phosphorylation of signal transducers and activators of transcription 5b and 3 by activated JAK2 kinase 1996
    1995 The amino-terminal portion of the JAK2 protein kinase is necessary for binding and phosphorylation of the granulocyte-macrophage colony-stimulating factor receptor βc chain.  Journal of Biological Chemistry.  270:13814-13818. 1995
    1995 Regions of the JAK2 tyrosine kinase required for coupling to the growth hormone receptor.  Journal of Biological Chemistry.  270:14776-14785. 1995
    1994 Interaction of the growth hormone receptor cytoplasmic domain with the JAK2 tyrosine kinase.  Endocrinology.  135:2228-2239. 1994
    1994 Treatment of IM-9 cells with human growth hormone (GH) promotes rapid disulfide linkage of the GH receptor.  Endocrinology.  135:148-156. 1994
    1992 Erratum: Mutagenesis of T cell antigen receptor ζ chain tyrosine residues. Effects on tyrosine phosphorylation and lymphokine production (Journal of Biological Chemistry (1992) 267 (13656-13660)).  Journal of Biological Chemistry.  267:19752. 1992
    1992 Mutagenesis of T cell antigen receptor ζ chain tyrosine residues. Effects on tyrosine phosphorylation and lymphokine production.  Journal of Biological Chemistry.  267:13656-13660. 1992
    1991 Localization of type I iodothyronine 5'-deiodinase to the basolateral plasma membrane in renal cortical epithelial cells.  Journal of Biological Chemistry.  266:11262-11269. 1991
    1991 Structure/function analysis of the invariant subunits of the T cell antigen receptor.  Seminars in Immunology.  3:299-311. 1991
    1990 The structure and signalling functions of the invariant T cell receptor components.  Seminars in Immunology.  2:89-97. 1990
    1990 Family of disulphide-linked dimers containing the ζ and η chains of the T-cell receptor and the γ chain of Fc receptors.  Nature.  347:189-191. 1990
    1990 Structural mutations of the T cell receptor ζ chain and its role in T cell activation.  Science.  249:174-177. 1990
    1990 The diagnosis of acromegaly: Value of inferior petrosal sinus sampling.  American Journal of Roentgenology.  154:1075-1077. 1990
    1989 Activation-driven programmed cell death and T cell receptor ζη expression.  Science.  246:1162-1165. 1989
    1989 Biochemical characterization of the η chain of the T-cell receptor. A unique subunit related to ξ.  Journal of Biological Chemistry.  264:14812-14817. 1989
    1989 Preoperative lateralization of pituitary microadenomas by petrosal sinus sampling: Utility in two patients with non-ACTH-secreting tumors.  American Journal of Medicine.  87:679-682. 1989
    1989 Role of the zeta chain in the expression of the T cell antigen receptor: Genetic reconstitution studies 1989
    1983 Differential sensitivity of brain iodothyronine 5'-deiodinases to sulfhydryl-blocking reagents.  Molecular and Cellular Endocrinology.  33:321-327. 1983

    Book

    Year Title Altmetric
    2014 Recombinant growth hormone therapy for cystic fibrosis in children and young adults.  Ed. 109.  2014

    Principal Investigator On

    Investigator On

    Teaching Activities

  • 28-471 - ENDOCRINOLOGY & METABOLISM (Fall Term 2018) 2018
  • 28-471 - ENDOCRINOLOGY & METABOLISM (Fall Term 2018) 2018
  • 28-471 - ENDOCRINOLOGY & METABOLISM (Fall Term 2018) 2018
  • 28-471 - ENDOCRINOLOGY & METABOLISM (Spring Term 2018) 2018
  • 28-471 - ENDOCRINOLOGY & METABOLISM (Spring Term 2018) 2018
  • 28-471 - ENDOCRINOLOGY & METABOLISM (Spring Term 2018) 2018
  • 28-471 - ENDOCRINOLOGY & METABOLISM (Spring Term 2018) 2018
  • 28-471 - ENDOCRINOLOGY & METABOLISM (Spring Term 2018) 2018
  • 28-471 - ENDOCRINOLOGY & METABOLISM (Fall Term 2017) 2017
  • 28-471 - ENDOCRINOLOGY & METABOLISM (Fall Term 2017) 2017
  • 28-471 - ENDOCRINOLOGY & METABOLISM (Fall Term 2017) 2017
  • 28-471 - ENDOCRINOLOGY & METABOLISM (Spring Term 2017) 2017
  • 28-471 - ENDOCRINOLOGY & METABOLISM (Spring Term 2017) 2017
  • 28-471 - ENDOCRINOLOGY & METABOLISM (Spring Term 2017) 2017
  • 28-471 - ENDOCRINOLOGY & METABOLISM (Spring Term 2017) 2017
  • 28-471 - ENDOCRINOLOGY & METABOLISM (Fall Term 2016) 2016
  • 28-471 - ENDOCRINOLOGY & METABOLISM (Fall Term 2016) 2016
  • 28-471 - ENDOCRINOLOGY & METABOLISM (Fall Term 2016) 2016
  • 28-471 - ENDOCRINOLOGY & METABOLISM (Fall Term 2016) 2016
  • 28-471 - ENDOCRINOLOGY & METABOLISM (Fall Term 2016) 2016
  • 28-471 - ENDOCRINOLOGY & METABOLISM (Spring Term 2016) 2016
  • 28-471 - ENDOCRINOLOGY & METABOLISM (Fall Term 2015) 2015
  • 28-471 - ENDOCRINOLOGY & METABOLISM (Spring Term 2015) 2015
  • 28-471 - ENDOCRINOLOGY & METABOLISM (Spring Term 2015) 2015
  • 28-471 - ENDOCRINOLOGY & METABOLISM (Fall Term 2014) 2014
  • 28-471 - ENDOCRINOLOGY & METABOLISM (Fall Term 2014) 2014
  • 28-471 - ENDOCRINOLOGY & METABOLISM (Spring Term 2014) 2014
  • 28-471 - ENDOCRINOLOGY & METABOLISM (Spring Term 2013) 2013
  • 28-471 - ENDOCRINOLOGY & METABOLISM (Spring Term 2013) 2013
  • 28-471 - ENDOCRINOLOGY & METABOLISM (Spring Term 2013) 2013
  • 28-471 - ENDOCRINOLOGY & METABOLISM (Spring Term 2013) 2013
  • 28-471 - ENDOCRINOLOGY & METABOLISM (Spring Term 2013) 2013
  • 28-471 - ENDOCRINOLOGY & METABOLISM (Spring Term 2013) 2013
  • 28-471 - ENDOCRINOLOGY & METABOLISM (Spring Term 2013) 2013
  • 28-471 - ENDOCRINOLOGY & METABOLISM (Spring Term 2013) 2013
  • 28-471 - ENDOCRINOLOGY & METABOLISM (Spring Term 2013) 2013
  • 28-471 - ENDOCRINOLOGY & METABOLISM (Fall Term 2012) 2012
  • 28-471 - ENDOCRINOLOGY & METABOLISM (Fall Term 2012) 2012
  • 28-471 - ENDOCRINOLOGY & METABOLISM (Fall Term 2012) 2012
  • 28-471 - ENDOCRINOLOGY & METABOLISM (Fall Term 2012) 2012
  • 28-471 - ENDOCRINOLOGY & METABOLISM (Fall Term 2012) 2012
  • 28-471 - ENDOCRINOLOGY & METABOLISM (Fall Term 2012) 2012
  • 28-471 - ENDOCRINOLOGY & METABOLISM (Fall Term 2012) 2012
  • 28-471 - ENDOCRINOLOGY & METABOLISM (Fall Term 2012) 2012
  • 28-471 - ENDOCRINOLOGY & METABOLISM (Fall Term 2012) 2012
  • 28-471 - ENDOCRINOLOGY & METABOLISM (Fall Term 2012) 2012
  • 28-471 - ENDOCRINOLOGY & METABOLISM (Spring Term 2011) 2011
  • 28-471 - ENDOCRINOLOGY & METABOLISM (Spring Term 2011) 2011
  • 28-471 - ENDOCRINOLOGY & METABOLISM (Spring Term 2011) 2011
  • 28-471 - ENDOCRINOLOGY & METABOLISM (Spring Term 2011) 2011
  • 28-471 - ENDOCRINOLOGY & METABOLISM (Spring Term 2011) 2011
  • 28-471 - ENDOCRINOLOGY & METABOLISM (Spring Term 2011) 2011
  • 28-471 - ENDOCRINOLOGY & METABOLISM (Spring Term 2011) 2011
  • 28-471 - ENDOCRINOLOGY & METABOLISM (Fall Term 2010) 2010
  • 28-471 - ENDOCRINOLOGY & METABOLISM (Fall Term 2010) 2010
  • 28-471 - ENDOCRINOLOGY AND METABOLISM (Spring Term 2010) 2010
  • 28-471 - ENDOCRINOLOGY AND METABOLISM (Spring Term 2010) 2010
  • 28-471 - ENDOCRINOLOGY AND METABOLISM (Spring Term 2010) 2010
  • 28-471 - ENDOCRINOLOGY AND METABOLISM (Spring Term 2010) 2010
  • 28-471 - ENDOCRINOLOGY AND METABOLISM (Fall Term 2009) 2009
  • 28-471 - ENDOCRINOLOGY AND METABOLISM (Fall Term 2009) 2009
  • 28-471 - ENDOCRINOLOGY AND METABOLISM (Fall Term 2009) 2009
  • 28-471 - ENDOCRINOLOGY AND METABOLISM (Fall Term 2009) 2009
  • 28-471 - ENDOCRINOLOGY AND METABOLISM (Spring Term 2009) 2009
  • 28-471 - ENDOCRINOLOGY AND METABOLISM (Spring Term 2009) 2009
  • 28-471 - ENDOCRINOLOGY AND METABOLISM (Fall Term 2008) 2008
  • 28-471 - ENDOCRINOLOGY AND METABOLISM (Spring Term 2008) 2008
  • 28-471 - ENDOCRINOLOGY AND METABOLISM (Spring Term 2008) 2008
  • 28-471 - ENDOCRINOLOGY AND METABOLISM (Spring Term 2008) 2008
  • 28-471 - ENDOCRINOLOGY AND METABOLISM (Fall Term 2007) 2007

    • Education And Training

  • Doctor of Medicine in Endocrinology, Harvard University 1984
  • Barnes Hospital, Internship 1985
  • Barnes Hospital, Residency 1987
  • National Institute of Health, Postdoctoral Fellowship 1991
  • Warren G. Magnuson Clinical Center, Postdoctoral Fellowship 1990

    • Full Name

  • Stuart Frank